Oesophagostomum dentatum Extract Modulates T Cell-Dependent Immune Responses to Bystander Antigens and Prevents the Development of Allergy in Mice

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Schabussova, Irma ^a   Ul Haq, Onisa ^a   Hoflehner, Elisabeth ^a   Akgün, Johnnie ^a   Wagner, Angelika ^a   Loupal, Gerhard ^b   Joachim, Anja ^b   Ruttkowski, Bärbel ^b   Maizels, Rick M ^c   Wiedermann, Ursula ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN M; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 4; INTERLEUKIN 5; MICROBIAL PRODUCTS NOT CLASSIFIED ELSEWHERE; OESOPHAGOSTOMUM DENTATUM EXTRACT; POLLEN ANTIGEN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIGEN PRESENTING CELL; ARTICLE; BASOPHIL DEGRANULATION; BIRCH; CELL CULTURE; CELL STIMULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; DISEASE MODEL; EOSINOPHIL; FEMALE; HELPER CELL; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOREGULATION; INFLAMMATORY INFILTRATE; LUNG ALVEOLUS CELL; LUNG LAVAGE; MESENTERY LYMPH NODE; MOUSE; MUCUS SECRETION; NONHUMAN; OESOPHAGOSTOMUM; OESOPHAGOSTOMUM DENTATUM; POLLEN ALLERGY; PROVOCATION TEST; RESPIRATORY TRACT ALLERGY; SENSITIZATION; SPLEEN CELL; TH2 CELL; THERAPY WITH HELMINTHS; THERMOSTABILITY; THYMUS;

ALLERGENS; ANIMALS; ANTIGENS, PLANT; BASOPHILS; BYSTANDER EFFECT; COMPLEX MIXTURES; DENDRITIC CELLS; HUMANS; HYPERSENSITIVITY; IMMUNITY, INNATE; IMMUNOGLOBULIN E; IMMUNOMODULATION; INTERLEUKIN-10; MALE; MICE; MICE, INBRED BALB C; OESOPHAGOSTOMUM; POLLEN; T-LYMPHOCYTES, REGULATORY; TH2 CELLS; THYMUS GLAND; TRANSFORMING GROWTH FACTOR BETA;

MUS; OESOPHAGOSTOMUM DENTATUM; VERMES;

EID: 84879774160     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067544     Document Type: Article

References (67)

1. Maizels RM, Hewitson JP, Smith KA, (2012) Susceptibility and immunity to helminth parasites. Curr Opin Immunol 24: 459-466.
2. Hartgers FC, Obeng BB, Kruize YC, Duijvestein M, de Breij A, et al. (2008) Lower expression of TLR2 and SOCS-3 is associated with Schistosoma haematobium infection and with lower risk for allergic reactivity in children living in a rural area in Ghana. PLoS Negl Trop Dis 2: e227.
3. Flohr C, Tuyen LN, Lewis S, Quinnell R, Minh TT, et al. (2006) Poor sanitation and helminth infection protect against skin sensitization in Vietnamese children: A cross-sectional study. J Allergy Clin Immunol 118: 1305-1311.
4. Rodrigues LC, Newcombe PJ, Cunha SS, Alcantara-Neves NM, Genser B, et al. (2008) Early infection with Trichuris trichiura and allergen skin test reactivity in later childhood. Clin Exp Allergy 38: 1769-1777.
5. Alcantara-Neves NM, Veiga RV, Dattoli VC, Fiaccone RL, Esquivel R, et al. (2012) The effect of single and multiple infections on atopy and wheezing in children. J Allergy Clin Immunol 129: 359-367, 367 e351-353.
6. Lynch NR, Hagel I, Perez M, Di Prisco MC, Lopez R, et al. (1993) Effect of anthelmintic treatment on the allergic reactivity of children in a tropical slum. J Allergy Clin Immunol 92: 404-411.
7. van den Biggelaar AH, Rodrigues LC, van Ree R, van der Zee JS, Hoeksma-Kruize YC, et al. (2004) Long-term treatment of intestinal helminths increases mite skin-test reactivity in Gabonese schoolchildren. J Infect Dis 189: 892-900.
8. Flohr C, Tuyen LN, Quinnell RJ, Lewis S, Minh TT, et al. (2010) Reduced helminth burden increases allergen skin sensitization but not clinical allergy: a randomized, double-blind, placebo-controlled trial in Vietnam. Clin Exp Allergy 40: 131-142.
9. Endara P, Vaca M, Chico ME, Erazo S, Oviedo G, et al. (2010) Long-term periodic anthelmintic treatments are associated with increased allergen skin reactivity. Clin Exp Allergy 40: 1669-1677.
10. Fleming JO, Isaak A, Lee JE, Luzzio CC, Carrithers MD, et al. (2011) Probiotic helminth administration in relapsing-remitting multiple sclerosis: a phase 1 study. Mult Scler 17: 743-754.
11. Summers RW, Elliott DE, Qadir K, Urban JF Jr, Thompson R, et al. (2003) Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease. Am J Gastroenterol 98: 2034-2041.
12. Summers RW, Elliott DE, Urban JF Jr, Thompson R, Weinstock JV, (2005) Trichuris suis therapy in Crohn's disease. Gut 54: 87-90.
13. Summers RW, Elliott DE, Urban JF Jr, Thompson RA, Weinstock JV, (2005) Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology 128: 825-832.
14. Bager P, Arnved J, Ronborg S, Wohlfahrt J, Poulsen LK, et al. (2012) Trichuris suis ova therapy for allergic rhinitis: a randomized, double-blind, placebo-controlled clinical trial. J Allergy Clin Immunol 125: 123-130 e121-123.
15. Bourke CD, Mutapi F, Nausch N, Photiou DM, Poulsen LK, et al. (2012) Trichuris suis ova therapy for allergic rhinitis does not affect allergen-specific cytokine responses despite a parasite-specific cytokine response. Clin Exp Allergy 42: 1582-1595.
16. Feary J, Venn A, Brown A, Hooi D, Falcone FH, et al. (2009) Safety of hookworm infection in individuals with measurable airway responsiveness: a randomized placebo-controlled feasibility study. Clin Exp Allergy 39: 1060-1068.
17. Feary JR, Venn AJ, Mortimer K, Brown AP, Hooi D, et al. (2010) Experimental hookworm infection: a randomized placebo-controlled trial in asthma. Clin Exp Allergy 40: 299-306.
18. McSorley HJ, Gaze S, Daveson J, Jones D, Anderson RP, et al. (2011) Suppression of inflammatory immune responses in celiac disease by experimental hookworm infection. PLoS One 6: e24092.
19. Kuijk LM, Klaver EJ, Kooij G, van der Pol SM, Heijnen P, et al. (2012) Soluble helminth products suppress clinical signs in murine experimental autoimmune encephalomyelitis and differentially modulate human dendritic cell activation. Mol Immunol 51: 210-218.
20. Zheng X, Hu X, Zhou G, Lu Z, Qiu W, et al. (2008) Soluble egg antigen from Schistosoma japonicum modulates the progression of chronic progressive experimental autoimmune encephalomyelitis via Th2-shift response. J Neuroimmunol 194: 107-114.
21. Johnston MJ, Wang A, Catarino ME, Ball L, Phan VC, et al. (2010) Extracts of the rat tapeworm, Hymenolepis diminuta, suppress macrophage activation in vitro and alleviate chemically induced colitis in mice. Infect Immun 78: 1364-1375.
22. Trujillo-Vargas CM, Werner-Klein M, Wohlleben G, Polte T, Hansen G, et al. (2007) Helminth-derived products inhibit the development of allergic responses in mice. Am J Respir Crit Care Med 175: 336-344.
23. McSorley HJ, O'Gorman MT, Blair N, Sutherland TE, Filbey KJ, et al. (2012) Suppression of type 2 immunity and allergic airway inflammation by secreted products of the helminth Heligmosomoides polygyrus. Eur J Immunol.
24. Lee KH, Park HK, Jeong HJ, Park SK, Lee SJ, et al. (2008) Immunization of proteins from Toxascaris leonina adult worm inhibits allergic specific Th2 response. Vet Parasitol 156: 216-225.
25. Cardoso LS, Oliveira SC, Goes AM, Oliveira RR, Pacifico LG, et al. (2010) Schistosoma mansoni antigens modulate the allergic response in a murine model of ovalbumin-induced airway inflammation. Clin Exp Immunol 160: 266-274.
26. Gasser RB, Cottee P, Nisbet AJ, Ruttkowski B, Ranganathan S, et al. (2007) Oesophagostomum dentatum: potential as a model for genomic studies of strongylid nematodes, with biotechnological prospects. Biotechnol Adv 25: 281-293.
27. Slotved HC, Barnes EH, Bjorn H, Christensen CM, Eriksen L, et al. (1996) Recovery of Oesophagostomum dentatum from pigs by isolation of parasites migrating from large intestinal contents embedded in agar-gel. Vet Parasitol 63: 237-245.
28. Lutz MB, Kukutsch N, Ogilvie AL, Rossner S, Koch F, et al. (1999) An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 223: 77-92.
29. Schabussova I, Hufnagl K, Tang ML, Hoflehner E, Wagner A, et al. (2012) Perinatal maternal administration of Lactobacillus paracasei NCC 2461 prevents allergic inflammation in a mouse model of birch pollen allergy. PLoS One 7: e40271.
30. Hufnagl K, Wagner B, Winkler B, Baier K, Hochreiter R, et al. (2003) Induction of mucosal tolerance with recombinant Hev b 1 and recombinant Hev b 3 for prevention of latex allergy in BALB/c mice. Clin Exp Immunol 133: 170-176.
31. Allen JE, Maizels RM, (2011) Diversity and dialogue in immunity to helminths. Nat Rev Immunol 11: 375-388.
32. Phythian-Adams AT, Cook PC, Lundie RJ, Jones LH, Smith KA, et al. (2010) CD11c depletion severely disrupts Th2 induction and development in vivo. J Exp Med 207: 2089-2096.
33. Doetze A, Satoguina J, Burchard G, Rau T, Loliger C, et al. (2000) Antigen-specific cellular hyporesponsiveness in a chronic human helminth infection is mediated by T(h)3/T(r)1-type cytokines IL-10 and transforming growth factor-beta but not by a T(h)1 to T(h)2 shift. Int Immunol 12: 623-630.
34. Smits HH, Everts B, Hartgers FC, Yazdanbakhsh M, (2010) Chronic helminth infections protect against allergic diseases by active regulatory processes. Curr Allergy Asthma Rep 10: 3-12.
35. Taylor MD, van der Werf N, Maizels RM T cells in helminth infection: the regulators and the regulated. Trends Immunol 33: 181-189.
36. Elias D, Britton S, Aseffa A, Engers H, Akuffo H, (2008) Poor immunogenicity of BCG in helminth infected population is associated with increased in vitro TGF-beta production. Vaccine 26: 3897-3902.
37. Flohr C, Quinnell RJ, Britton J, (2009) Do helminth parasites protect against atopy and allergic disease? Clin Exp Allergy 39: 20-32.
38. Donnelly S, Dalton JP, Loukas A, (2006) Proteases in helminth- and allergen- induced inflammatory responses. Chem Immunol Allergy 90: 45-64.
39. Lack G, Bradley KL, Hamelmann E, Renz H, Loader J, et al. (1996) Nebulized IFN-gamma inhibits the development of secondary allergic responses in mice. J Immunol 157: 1432-1439.
40. Gavett SH, O'Hearn DJ, Li X, Huang SK, Finkelman FD, et al. (1995) Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J Exp Med 182: 1527-1536.
41. Hansen G, Berry G, DeKruyff RH, Umetsu DT, (1999) Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. J Clin Invest 103: 175-183.
42. Randolph DA, Carruthers CJ, Szabo SJ, Murphy KM, Chaplin DD, (1999) Modulation of airway inflammation by passive transfer of allergen-specific Th1 and Th2 cells in a mouse model of asthma. J Immunol 162: 2375-2383.
43. Wilson MS, Taylor MD, Balic A, Finney CA, Lamb JR, et al. (2005) Suppression of allergic airway inflammation by helminth-induced regulatory T cells. J Exp Med 202: 1199-1212.
44. Taylor MD, van der Werf N, Harris A, Graham AL, Bain O, et al. (2009) Early recruitment of natural CD4+ Foxp3+ Treg cells by infective larvae determines the outcome of filarial infection. Eur J Immunol 39: 192-206.
45. Baumgart M, Tompkins F, Leng J, Hesse M, (2006) Naturally occurring CD4+Foxp3+ regulatory T cells are an essential, IL-10-independent part of the immunoregulatory network in Schistosoma mansoni egg-induced inflammation. J Immunol 176: 5374-5387.
46. Grainger JR, Smith KA, Hewitson JP, McSorley HJ, Harcus Y, et al. (2010) Helminth secretions induce de novo T cell Foxp3 expression and regulatory function through the TGF-beta pathway. J Exp Med 207: 2331-2341.
47. Ilic N, Worthington JJ, Gruden-Movsesijan A, Travis MA, Sofronic-Milosavljevic L, et al. (2011) Trichinella spiralis antigens prime mixed Th1/Th2 response but do not induce de novo generation of Foxp3+ T cells in vitro. Parasite Immunol 33: 572-582.
48. Wohlleben G, Trujillo C, Muller J, Ritze Y, Grunewald S, et al. (2004) Helminth infection modulates the development of allergen-induced airway inflammation. Int Immunol 16: 585-596.
49. Schnoeller C, Rausch S, Pillai S, Avagyan A, Wittig BM, et al. (2008) A helminth immunomodulator reduces allergic and inflammatory responses by induction of IL-10-producing macrophages. J Immunol 180: 4265-4272.
50. Schabussova I, Hufnagl K, Wild C, Nutten S, Zuercher AW, et al. (2011) Distinctive anti-allergy properties of two probiotic bacterial strains in a mouse model of allergic poly-sensitization. Vaccine 29: 1981-1990.
51. Schabussova I, Wiedermann U, (2008) Lactic acid bacteria as novel adjuvant systems for prevention and treatment of atopic diseases. Curr Opin Allergy Clin Immunol 8: 557-564.
52. Kilian HD, Nielsen G, (1989) Cell-mediated and humoral immune responses to BCG and rubella vaccinations and to recall antigens in onchocerciasis patients. Trop Med Parasitol 40: 445-453.
53. Rougemont A, Boisson-Pontal ME, Pontal PG, Gridel F, Sangare S, (1977) Tuberculin skin tests and B.C.G. vaccination in hyperendemic area of onchocerciasis. Lancet 1: 309.
54. Stewart GR, Boussinesq M, Coulson T, Elson L, Nutman T, et al. (1999) Onchocerciasis modulates the immune response to mycobacterial antigens. Clin Exp Immunol 117: 517-523.
55. Elias D, Wolday D, Akuffo H, Petros B, Bronner U, et al. (2001) Effect of deworming on human T cell responses to mycobacterial antigens in helminth-exposed individuals before and after bacille Calmette-Guerin (BCG) vaccination. Clin Exp Immunol 123: 219-225.
56. van Riet E, Adegnika AA, Retra K, Vieira R, Tielens AG, et al. (2007) Cellular and humoral responses to influenza in gabonese children living in rural and semi-urban areas. J Infect Dis 196: 1671-1678.
57. Cooper PJ, Espinel I, Paredes W, Guderian RH, Nutman TB, (1998) Impaired tetanus-specific cellular and humoral responses following tetanus vaccination in human onchocerciasis: a possible role for interleukin-10. J Infect Dis 178: 1133-1138.
58. Cooper PJ, Espinel I, Wieseman M, Paredes W, Espinel M, et al. (1999) Human onchocerciasis and tetanus vaccination: impact on the postvaccination antitetanus antibody response. Infect Immun 67: 5951-5957.
59. Noland GS, Chowdhury DR, Urban JF Jr, Zavala F, Kumar N, (2010) Helminth infection impairs the immunogenicity of a Plasmodium falciparum DNA vaccine, but not irradiated sporozoites, in mice. Vaccine 28: 2917-2923.
60. Esen M, Mordmuller B, de Salazar PM, Adegnika AA, Agnandji ST, et al. (2012) Reduced antibody responses against Plasmodium falciparum vaccine candidate antigens in the presence of Trichuris trichiura. Vaccine.
61. Hartmann W, Haben I, Fleischer B, Breloer M, (2011) Pathogenic nematodes suppress humoral responses to third-party antigens in vivo by IL-10-mediated interference with Th cell function. J Immunol 187: 4088-4099.
62. Mond JJ, Lees A, Snapper CM, (1995) T cell-independent antigens type 2. Annu Rev Immunol 13: 655-692.
63. Boitelle A, Di Lorenzo C, Scales HE, Devaney E, Kennedy MW, et al. (2005) Contrasting effects of acute and chronic gastro-intestinal helminth infections on a heterologous immune response in a transgenic adoptive transfer model. Int J Parasitol 35: 765-775.
64. Hartmann W, Eschbach ML, Breloer M (2012) Strongyloides ratti infection modulates B and T cell responses to third party antigens. Exp Parasitol.
65. Joachim A, Ruttkowski B, Daugschies A, (2001) Characterisation of stage-specific proteins of Oesophagostomum dentatum by preparative isoelectric focusing and lectin blotting. Parasitol Int 50: 41-45.
66. Joachim A, Ruttkowski B, Daugschies A, (1999) Changing surface antigen and carbohydrate patterns during the development of Oesophagostomum dentatum. Parasitology 119 (Pt 5): 491-501.
67. Yan S, Bleuler-Martinez S, Plaza DF, Kunzler M, Aebi M, et al. (2012) Galactosylated fucose epitopes in nematodes: increased expression in a Caenorhabditis mutant associated with altered lectin sensitivity and occurrence in parasitic species. J Biol Chem 287: 28276-28290.